B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

If you've ever pulled a late night at the college library or at your office, you may have reached for an energy drink or two ...

French biotech ImCheck Therapeutics is preparing to showcase encouraging interim results for its investigational monoclonal ...

Medical debt is the number one reason that people in the United States file for bankruptcy, and for many, like cancer ...

John Chandler of Whitefish Bay has gone on a run every day since 1981 despite enduring illness and surgery. Now he’s closing ...

MHH haematologists successfully treat seriously ill patients with acquired haemophilia A with CAR-T cells.

An NIH developed vaccine virtually eliminated the most common cause of bacterial meningitis, and NIH-backed therapies have ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

TURKU, FI / ACCESS Newswire / May 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - New preclinical data published in Scientific Reports confirms CLEVER-1 inhibition by Bexmarilimab increases ...

TURKU, FI / ACCESS Newswire / May 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - New preclinical data published in Scientific Reports confirms CLEVER-1 inhibition by Bexmarilimab increases a ...